Chronic myelomonocytic leukemia and blastic plasmacytoid dendritic cell neoplasm. A case report and systematic review

Andrea Espasa(Universitat Autònoma de Barcelona), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Gustavo Tapia(Hospital Universitari Germans Trias i Pujol), Jordi Juncà(Universitat Autònoma de Barcelona), Lurdes Zamora(Universitat Autònoma de Barcelona), Marta Cabezón(Universitat Autònoma de Barcelona), Minerva Raya(Universitat Autònoma de Barcelona), Sara Vergara(Universitat Autònoma de Barcelona), Marc Sorigué(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol)
Cytometry Part B Clinical Cytometry
August 24, 2020
10.1002/cyto.b.21932
Cited by 8

Related Papers

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
|New England Journal of Medicine|2022|309
Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
|Blood|2010|233
Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
|Haematologica|2011|215
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients
|Blood|2013|189
Human immunodeficiency virus‐associated plasmablastic lymphoma
|Cancer|2012|178